
8.27 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 6.00 Today|||52-Week Range 14.40 | -40.29% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $250.2M |
Alpine Immune Sciences, Inc. 188 East Blaine Street Seattle Washington 98102 |
Mitchell H. Gold | Executive Chairman & Chief Executive Officer |
Stanford L. Peng | President & Head-Research & Development |
Thaedra Thullberry | Finance Director |
James Paul Rickey | Chief Financial Officer, Secretary & Senior VP |
Wayne R. Gombotz | Chief Technology Officer |